ABSTRACT
BACKGROUND: Subjects with neurological disease (ND) usually show impaired performance during sit-to-stand and stand-to-sit tasks, with a consequent reduction in their mobility levels. OBJECTIVE: To determine the measurement properties and feasibility previously investigated for clinical tests that evaluate sit-to-stand and stand-to-sit in subjects with ND. METHOD: A systematic literature review following the PRISMA (Preferred Reporting Items for Systematic reviews and Meta-Analyses) protocol was performed. Systematic literature searches of databases (MEDLINE/SCIELO/LILACS/PEDro) were performed to identify relevant studies. In all studies, the following inclusion criteria were assessed: investigation of any measurement property or the feasibility of clinical tests that evaluate sit-to-stand and stand-to-sit tasks in subjects with ND published in any language through December 2012. The COSMIN checklist was used to evaluate the methodological quality of the included studies. RESULTS: Eleven studies were included. The measurement properties/feasibility were most commonly investigated for the five-repetition sit-to-stand test, which showed good test-retest reliability (Intraclass Correlation Coefficient:ICC=0.94-0.99) for subjects with stroke, cerebral palsy and dementia. The ICC values were higher for this test than for the number of repetitions in the 30-s test. The five-repetition sit-to-stand test also showed good inter/intra-rater reliabilities (ICC=0.97-0.99) for stroke and inter-rater reliability (ICC=0.99) for subjects with Parkinson disease and incomplete spinal cord injury. For this test, the criterion-related validity for subjects with stroke, cerebral palsy and incomplete spinal cord injury was, in general, moderate (correlation=0.40-0.77), and the feasibility and safety were good for subjects with Alzheimer's disease. CONCLUSIONS: The five-repetition sit-to-stand test was used more often in subjects with ND, ...
CONTEXTUALIZAÇÃO: Indivíduos acometidos por doença neurológica (DN) comumente apresentam limitação no desempenho do levantar/sentar em cadeira, com consequente redução do nível de mobilidade. OBJETIVO: Determinar as propriedades de medida/aplicabilidade de testes clínicos que avaliam o levantar/sentar em cadeira em indivíduos com DN. MÉTODO: Trata-se de revisão sistemática da literatura, seguindo o PRISMA (Preferred Reporting Items for Systematic reviews and Meta-Analyses). As bases de dados (MEDLINE/SCIELO/LILACS/PEDro) foram pesquisadas pela combinação de termos referentes aos testes e propriedades. Os critérios de inclusão foram: investigar propriedade de medida/aplicabilidade de testes clínicos que avaliem o levantar/sentar em cadeira em indivíduos com DN, publicado em qualquer idioma até dezembro/2012; qualidade metodológica avaliada pelo COSMIN. RESULTADOS: Foram incluídos onze estudos. Grande parte das propriedades investigadas foi para o "teste de cinco repetições de levantar/sentar", que apresentou principalmente boa confiabilidade teste-reteste (coeficiente de correlação intraclasse: CCI=0,94-0,99) para acidente vascular encefálico (AVE), paralisia cerebral e demência e, para esse último, obteve valores de CCI superiores aos do "teste de número de repetições de levantar/sentar em 30s" (CCI=0,84). O teste de cinco repetições apresentou ainda boa confiabilidade inter/intraexaminador (CCI=0,97-0,99) para AVE e inter (CCI=0,99) para Doença de Parkinson e lesão medular incompleta (LMI), validade de critério para AVE, paralisia cerebral, LMI e esclerose múltipla, com resultados predominantemente moderados (correlação=0,4-0,77), e boa aplicabilidade clínica/segurança para Doença de Alzheimer. ...